Literature DB >> 6693833

Muramyl peptides. Variation of somnogenic activity with structure.

J M Krueger, J Walter, M L Karnovsky, L Chedid, J P Choay, P Lefrancier, E Lederer.   

Abstract

Sleep-promoting activities of muramyl dipeptide (MDP) (NAc-Mur-L-ala-D-isogln) and the naturally occurring muramyl peptide(s), factor S, have recently been demonstrated. We now have amplified our understanding of structural requirements for somnogenic activity. The effects of several analogs of MDP on rabbit slow-wave sleep are presented and these results are compared to the dose-response relationship for MDP. Some tentative conclusions as to structural requirements for somnogenic activity are presented; most notably, amidation of the free gamma-carboxyl of MDP and several of its analogs resulted in the loss of somnogenic activity. MDP also can induce febrile and immunostimulatory responses. In the present paper, we show that some analogs possess immunostimulatory and pyrogenic activity but not somnogenic activity, thus suggesting that these biological activities of muramyl peptides may, in part, be mediated by separate mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693833      PMCID: PMC2187212          DOI: 10.1084/jem.159.1.68

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animals.

Authors:  J R Pappenheimer; G Koski; V Fencl; M L Karnovsky; J Krueger
Journal:  J Neurophysiol       Date:  1975-11       Impact factor: 2.714

2.  Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.

Authors:  P Lefrancier; J Choay; M Derrien; I Lederman
Journal:  Int J Pept Protein Res       Date:  1977

Review 3.  Synthetic immunostimulants derived from the bacterial cell wall.

Authors:  E Lederer
Journal:  J Med Chem       Date:  1980-08       Impact factor: 7.446

4.  Sleep-promoting material from human urine and its relation to factor S from brain.

Authors:  J M Krueger; J Bacsik; J García-Arrarás
Journal:  Am J Physiol       Date:  1980-02

5.  Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine).

Authors:  P Lefrancier; M Derrien; I Lederman; F Nief; J Choay; E Lederer
Journal:  Int J Pept Protein Res       Date:  1978-04

6.  Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; T Shimono; K Harada; T Shiba
Journal:  Biken J       Date:  1976-03

7.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Factors in cerebrospinal fluid from goats that affect sleep and activity in rats.

Authors:  V Fencl; G Koski; J R Pappenheimer
Journal:  J Physiol       Date:  1971-08       Impact factor: 5.182

9.  Sleep-promoting effects of muramyl peptides.

Authors:  J M Krueger; J R Pappenheimer; M L Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  20 in total

1.  The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.

Authors:  E C Darcissac; M J Truong; J Dewulf; Y Mouton; A Capron; G M Bahr
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Authors:  G M Bahr; E C Darcissac; N Castéran; C Amiel; C Cocude; M J Truong; J Dewulf; A Capron; Y Mouton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

4.  Effect of muramyl peptides on mitochondrial respiration.

Authors:  N El-Jamal; G M Bahr; K S Echtay
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 5.  Sleep and Microbes.

Authors:  J M Krueger; M R Opp
Journal:  Int Rev Neurobiol       Date:  2016-08-31       Impact factor: 3.230

Review 6.  Central nervous system and peripheral immune functions and the sleep-wake system.

Authors:  H Moldofsky
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

7.  Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.

Authors:  M Parant; L Chedid
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.

Authors:  M Parant; L Chedid
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

10.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.